JUST IN: Hengrui, China’s largest drugmaker by market value, is set to begin trading in Hong Kong Friday after raising HK$9.9 billion ($1.3 billion) as listings pick up in the Asian financial hub, per Bloomberg.
#BinanceSquareTalks #GENIUSAct #SaylorBTCPurchase #billions #bitcoin